Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

EMA Says Benefits of Celgene’s Myeloma Drug Outweigh Risks Despite Increased Incidence of New Cancers

Agency recommends updating prescribing information for Revlimid and warning doctors of risks to patients.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »